Laxai Pharma, Ltd. Publishes Second Quarter Results and Adds New Business With Laxai Life Sciences, Inc. SOUTH PLAINFIELD, N.J., Aug. 26, 2010 (GLOBE NEWSWIRE) -- Laxai Pharma, Ltd. (the "Company") (OTCBB:LAXAF), an international pharmaceutical contract research organization ("CRO"), is pleased to...

Laxai Pharma Ltd. and UTA Capital LLC Agree to Extend Term of $1.44 Million Term Loan and Reduce Its Interest Rate NEW YORK, July 30, 2010 (GLOBE NEWSWIRE) -- Laxai Pharma Ltd. (the "Company") (OTCBB:LAXAF), an international pharmaceutical contract research organization ("CRO"), recently reached an agreement with...

Laxai Pharma Ltd. Completes Asset Purchase of a Clinical Research Services Company and Files Its Annual Report for 2009 NEW YORK, April 19, 2010 (GLOBE NEWSWIRE) -- Laxai Pharma Ltd. (OTCBB:LAXAF) (f/k/a NexGen Biofuels, Ltd.), a contract research organization ("CRO"), recently completed an asset purchase of OSR...

Laxai Pharma, Ltd. (f/k/a NexGen Biofuels, Ltd.) Completes Asset Purchase of OSR Solutions, Inc. as Platform Acquisition for Clinical Research Services NEW YORK, March 11, 2010 (GLOBE NEWSWIRE) -- Laxai Pharma, Ltd. (f/k/a NexGen Biofuels, Ltd.) (OTCBB:NXGNF) today announced that it has completed its first acquisition in the clinical research...